{
    "type": "ETP",
    "ucits": false,
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": false,
    "replication_method": "synthetic",
    "complex_factors": [
        "Leverage 3x exposure",
        "Synthetic replication via derivatives",
        "Daily rebalancing and compounding effects",
        "High risk indicator (7/7)",
        "Complex payoff structure linked to Solactive US AI Index",
        "Potential counterparty and collateral risk",
        "No capital protection",
        "Short recommended holding period (1 day)",
        "Liquidity risk and possible significant loss on early exit"
    ],
    "classification": "complex",
    "supporting_data": "The product is a 3x leveraged ETP Securities product aiming to deliver three times the daily performance of the Solactive US Artificial Intelligence Index. It uses derivatives centrally to achieve this leverage and synthetic exposure, which introduces counterparty and collateral risks that are difficult for retail investors to understand. The product has a high risk rating (7/7), no capital protection, and a recommended holding period of only one day due to compounding effects and volatility impact. The structure involves daily leverage rebalancing, which can cause returns to deviate significantly from the underlying index over longer holding periods. These features align with MiFID II criteria for complex instruments, particularly under Article 57 and ESMA guidelines, which exclude leveraged, synthetic, and derivative-embedded products from the non-complex category. The product is not UCITS compliant and is explicitly described as 'not simple and may be difficult to understand' in its KID, further supporting its classification as complex. Therefore, an appropriateness assessment is required before sale to retail clients."
}